Fortis facilitating sale of stakes owned by PE investors in SRL Diagnostics, says report
Updated : March 26, 2019 08:36 AM IST
IHH Healthcare Bhd, the new owner of Fortis, had earlier planned to buy out the private equity firms but withdrew the plan as the legal battle between the Singh brothers and Daiichi Sankyo persisted, the report said.
Fortis owns 57 percent in SRL Diagnostics, Resurgence Fund and IFC 7.5 percent each, New York Jacob Ballas Fund 16 percent while other shareholders own the remaining in SRL Diagnostics.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more